diabetes (insulin administration)
Conditions
Interventions
The intervention in this study is a specific needle with a length of 5 mm and 8
mm to be used with an insulin pen.
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: male and female adult patients diagnosed with Type 1 or Type 2 diabetes and using insulin for at least one year and have insulin injections with an insulin pen, have a BMI >= 30, have a skinfold thickness of > 10 mm at the injection sites, stable glycaemic control, hba1c between 6-10%, are capable of reading the written information and are prepared to, and capable of signing an informed consent.
Exclusion criteria
Exclusion criteria: patients who: change their own insulin dosage and are not prepared to keep an administration of these changes, are hypoglycaemia unaware, are pregnant or wish to become pregnant, have a BMI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hypoglycemia, local complaints, and patients preference. | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c , fructosamine, serum 1,5-Anhydroglucitol | — |
Countries
Netherlands
Outcome results
None listed